Crossmark

Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8+ T cell immune function in acute myeloid leukemia

Crossref DOI link: https://doi.org/10.1038/s41419-022-05357-9

Published Online: 2022-10-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ren, Jun

Tao, Yonghong

Peng, Meixi

Xiao, Qiaoling

Jing, Yipei

Huang, Junpeng

Yang, Jing

Lin, Can

Sun, Minghui

Lei, Li

Yang, Zesong

Yang, Zailin

Zhang, Ling https://orcid.org/0000-0003-1097-6034
License Information

Text and Data Mining valid from 2022-10-31

Version of Record valid from 2022-10-31
More Information

Article History

Received: 19 July 2022

Revised: 18 October 2022

Accepted: 19 October 2022

First Online: 31 October 2022

Competing interests

: The authors declare no competing interests.

: The animal experiments were approved by the Animal Ethics Committee of the Chongqing Medical University.

Document is current

Any future updates will be listed below